Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fusté, Anna Coma"'
Autor:
Hálfdánarson, Óskar, Zoëga, Helga, Aagaard, Lise, Bernardo, Miquel, Brandt, Lena, Fusté, Anna Coma, Furu, Kari, Garuoliené, Kristina, Hoffmann, Falk, Huybrechts, Krista F., Kalverdijk, Luuk J., Kawakami, Koji, Kieler, Helle, Kinoshita, Takuya, Litchfield, Melisa, López, Soffy C., Machado-Alba, Jorge E., Machado-Duque, Manuel E., Mahesri, Mufaddal, Nishtala, Prasad S., Pearson, Sallie-Anne, Reutfors, Johan, Saastamoinen, Leena K., Sato, Izumi, Schuiling-Veninga, Catharina C.M., Shyu, Yu-Chiau, Skurtveit, Svetlana, Verdoux, Hélène, Wang, Liang-Jen, Yahni, Corinne Zara, Bachmann, Christian J.
Publikováno v:
In European Neuropsychopharmacology October 2017 27(10):1064-1076
Autor:
Godman, Brian, Wilcock, Michael, Martin, Andrew, Bryson, Scott, Baumgärtel, Christoph, Bochenek, Tomasz, de Bruyn, Winne, Sović-Brkičić, Ljiljana, D’Agata, Marco, Fogele, Antra, Fusté, Anna Coma, Fraeyman, Jessica, Fürst, Jurij, Garuoliene, Kristina, Herholz, Harald, Hoffmann, Mikael, Jayathissa, Sisira, Kwon, Hye-Young, Langner, Irene, Kalaba, Marija, Karlsson, Eva Andersén, Laius, Ott, Markovic-Pekovic, Vanda, Magnusson, Einar, McTaggart, Stuart, Metcalfe, Scott, Bak Pedersen, Hanne, Piessnegger, Jutta, Ringerud, Anne Marthe, Selke, Gisbert W., Sermet, Catherine, Schiffers, Krijn, Skiold, Peter, Slabý, Juraj, Tomek, Dominik, Viksna, Anita, Vitry, Agnes, Zara, Corinne, Malmström, Rickard E
The manufacturer of pregabalin has a second use patent covering prescribing for neuropathic pain: its principal indication. The manufacturer has threatened legal action in the UK if generic pregabalin rather than Lyrica is prescribed for this indicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::d2334ad67368f4d1b1efae0adfe6bd4b
https://strathprints.strath.ac.uk/53359/1/Godman_etal_GABIJ_2015_Generic_pregabalin_current_situation_and_implications_for_health_authorities.pdf
https://strathprints.strath.ac.uk/53359/1/Godman_etal_GABIJ_2015_Generic_pregabalin_current_situation_and_implications_for_health_authorities.pdf